September 29th, 2009
Podcast 58: A repeat of the July 31 interview with the CDC’s Denise Jamieson on treating pregnant women who have suspected 2009 H1N1.
Podcast: Play in new window | Download
Subscribe: RSS
Pregnant women are at greater risk for flu complications. This week, we repeat a conversation with a CDC researcher who’d just published a paper in Lancet urging prompt treatment with antivirals, even in the face of pending lab results. Contact us at 1-617-440-4374. This week’s links:
- In Pregnancy, Treat Suspected H1N1 Promptly Without Awaiting Test Results
- Maternal Use of Sertaline, Citalopram Linked to Septal Heart Defects in Offspring
- HIV Vaccine Shows Unexpected, if Limited, Success
- Prostate-Specific Antigen Doesn’t Measure Up as a Screening Test
Categories: 2009 H1N1, antiviral drugs, pregnancy, Uncategorized
Tags: 2009 H1N1, antiviral drugs, birth defects, citalopram, Denise Jamieson, depression, HIV, influenza, pregnancy, prostate screening, PSA, sertraline, Thailand, vaccination
You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.
Comments are closed.
About the Podcast
Comments, suggestions, and story ideas welcome. Learn more about Clinical Conversations.
Follow us:
Most Commented
- Podcast 256 — Anthony Fauci: Talking with patients about COVID-19 (27)
- Podcast 266: Interferon and early treatment in COVID-19 bring good outcomes (8)
- Podcast 251: Intermittent fasting (7)
- Podcast 261: COVID-19 as a medical disaster (6)
- Podcast 214: Drug-drug interactions and bleeding risks with NOACs (6)
Subscribe to Clinical Conversations via Email
-
Tag Cloud
- 2009 H1N1 acute coronary syndromes aspirin blood pressure breast cancer cancer risk cardiovascular disease Cardiovascular risk clopidogrel dabigatran dementia depression diabetes Diabetes type 2 diet Elderly Emergency medicine epidemiology falls FDA glucose guidelines H1N1 Heart failure hemoglobin A1c hypertension influenza pain Patient care patients PPI pregnancy Prostate cancer prostate screening proton pump inhibitors public health Quality of care risk Rivaroxaban screening smoking stents stroke vaccination warfarin